Multiple upper gastrointestinal perforations in a 15-year-old patient treated with tocilizumab
- 12 March 2014
- journal article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 53 (9), 1713-1714
- https://doi.org/10.1093/rheumatology/keu032
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic ArthritisThe New England Journal of Medicine, 2012
- Overview of safety of non-biologic and biologic DMARDsRheumatology, 2012
- Factors associated with gastrointestinal perforation in a cohort of patients with rheumatoid arthritisArthritis Care & Research, 2012
- Lower gastrointestinal perforation in rheumatoid arthritis patients treated with conventional DMARDs or tocilizumab: a systematic literature reviewClinical Rheumatology, 2011
- Safety and efficacy of tocilizumab, an anti-IL-6-receptor monoclonal antibody, in patients with polyarticular-course juvenile idiopathic arthritisModern Rheumatology, 2011
- Tocilizumab: A Novel Humanized Anti-Interleukin 6 Receptor Antibody for the Treatment of Patients with Rheumatoid ArthritisTherapeutic Advances in Musculoskeletal Disease, 2011
- Clinical safety of tocilizumab in rheumatoid arthritisExpert Opinion on Drug Safety, 2010
- Tocilizumab dramatically ameliorated life-threatening diarrhea due to secondary amyloidosis associated with rheumatoid arthritisClinical Rheumatology, 2009